CN Stock MarketDetailed Quotes

Zhejiang Hisun Pharmaceutical (600267)

Watchlist
  • 10.89
  • -0.04-0.37%
Not Open May 19 15:00 CST
13.05BMarket Cap18.58P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Hisun Pharmaceutical (600267) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing6.5B61.58%
Pharmaceutical commerce3.9B36.94%
Other business128.76M1.22%
Other18.93M0.18%
CMO/CDMO/CRO业务7.8M0.07%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing6.5B61.58%
Pharmaceutical commerce3.9B36.94%
Other business128.76M1.22%
Other18.93M0.18%
CMO/CDMO/CRO业务7.8M0.07%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic area9.76B92.49%
Foreign region663.11M6.29%
Other business128.76M1.22%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.54%
Sample Name
Sample Code
 +4.71%
Sample Name
Sample Code
 0.00%
4
SHANGHAI PECHEM
00338
-0.81%
5
SINOPEC CORP
00386
-0.88%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +42.01%
Sample Name
Sample Code
 +32.82%
Sample Name
Sample Code
 +26.86%
4
Emdoor Information
001314
+25.83%
5
Digital China Group
000034
+20.88%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -